Genetic linkage studies were performed in 16 British families affected by X linked ocular albinism (XLOA) using RFLPs from the Xp22.3 region. Linkage was confirmed between the XLOA locus (OAI) and the loci DXS143 (dic56; Zmax= 15-90 at 0 = 0-0, confidence interval (CI) 0-0 035), DXS85 (782; Zmax = 15-67 at 0 = 0-04, CI=0O007-0O11), and DXS237 (GMGX9; Zmax= 12-65 at [0] [1] [2] [3] [4] [5] [6] [7] [8] In this study we report linkage analysis on 16 British families affected by XLOA using the DNA markers DXS237 (GMGX9), DXS143 (dic56), and DXS85 (782).
X linked ocular albinism (XLOA) is a cause of reduced visual acuity and nystagmus in males' and is associated with refractive errors, strabismus, iris translucency, fundus hypopigmentation, and foveal hypoplasia. 2 The effects of the mutant gene are not confined to the eyes: visual evoked potentials show evidence of abnormal neuronal crossing at the optic chiasm' and, although skin and hair pigmentation is normal, skin histology shows abnormal giant melanin granules termed macromelanoscomes45 in all affected males. 6 The vision of carrier females is normal, but ophthalmic examination shows a characteristic 'mud splattered' fundus appearance. 7 In this study we report linkage analysis on 16 British families affected by XLOA using the DNA markers DXS237 (GMGX9), DXS143 (dic56), and DXS85 (782).
Patients and methods

PATIENTS
Sixteen multigeneration British families affected by XLOA were systematically assessed by an ophthalmologist (SJC). Within each kindred all available family members had a full ophthalmic examination, including assessment of best corrected visual acuity, ocular movements, colour vision (Ishihara and City University plates), slit lamp examination to assess iris translucency, and ophthalmoscopy. Where possible a skin biopsy was performed in each adult.
Primary diagnostic criteria for affected males were reduced visual acuity, iris translucency, hypopigmented fundi, macromelanosomes on skin biopsy, and a family history consistent with X linked inheritance. In all families at least one male met these criteria. Genetic mapping of X linked ocular albinism: linkage analysis in British families There were eight subjects contributing recombinants with DXS237 or DXS85. These comprised six affected males, one normal male, and one 'at risk' female with definite clinical signs of the carrier state.
Multipoint linkage analysis showed that the most likely location for OAI is in the DXS85-DXS237 interval (figure) to give the order DXS85-(DXS143,OA1)-DXS237-XGXpter. A location between DXS85 and DXS237 was at least 12 x 104 times more likely than in adjacent intervals. The peak multipoint lod score was 26-9 with OAI placed 1-2 cM proximal to DXS143 (dic56), but this score was not significantly higher than for positions distal to this marker. OAI lies close to DXS143 but in the absence of recombinants the order of these loci could not be determined.
Discussion
This study confirms the localisation of the OAI locus to the Xp22.3 region. Previous studies have suggested that DXS85 (782) might be the most closely linked DNA marker with a cumulative lod score of 7 80 at zero recombination.25 This study places OAI distal to DXS85 at a recombination fraction of 0-04 with a maximum lod score of 15-67 and indicates that OAI may lie closer to DXS143 (dic56). No recombinants were found between OAI and DXS143. Analysis of recombinants in this study confirms localisation of OAI proximal to DXS237 and distal to DXS85, but absence of recombinants with DXS143 does not allow further localisation about this locus. No family had more than one subject recombinant for the markers DXS237 or DXS85. There is therefore no evidence of genetic heterogeneity of XLOA in the British population.
Recombinants between DXS143 and OAI have been reported but give conflicting information about the order. Bergen et al'5 described a normal male who was recombinant for DXS143 but non-recombinant for DXS237, placing OAI distal to DXS143. Schnur et al'6 reported an affected male who was recombinant for DXS143 and distal markers, placing OAI proximal to DXS143. Assuming correct diagnosis of XLOA in each study, these discrepancies are hard to explain. 
